|
|
Previous Article | Table of Contents | Next Article 
Constitutive activation of STAT proteins in primary lymphoid and myeloid
leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines
RM Weber-Nordt, C Egen, J Wehinger, W Ludwig, V Gouilleux-Gruart, R Mertelsmann and J Finke
Department of Hematology & Oncology, Albert-Ludwigs-University Medical
Center, Freiburg, Germany.
Although various molecular mechanisms of STAT protein (signal transducers
and activators of transcription) activation have been identified, little is
known about the functional role of STAT-dependent transcriptional
activation. Herein we report the constitutive nuclear localization,
phosphorylation, and DNA-binding activity of STAT proteins in leukemia
cells and lymphoma cell lines. With the use of oligonucleotide probes
derived from the Fc gamma RI promoter, the beta- casein promoter and a
STAT-binding element in the promoter of the Bci-2 gene constitutive
activation of STAT proteins was detected in untreated acute T- and
C/B-leukemia cells (3 of 5 and 12 of 19 patients, respectively). Supershift
analyses using Stats 1-6 specific antisera showed the constitutive DNA
binding activity of Stat5 in these cells. Confocal microscopy revealed the
nuclear localization of Stat5 and Western blot analyses showed tyrosine
phosphorylation of Stat5 in nuclear extracts of acute leukemia cells. In
contrast, peripheral blood mononuclear cells did not display constitutive
STAT-DNA interaction. Further studies were performed on freshly isolated
acute myeloid leukemia cells as well as on cell line derived K562,
lymphoblastoid cells (LCL), and Burkitt's lymphoma cells (BL). Fluorescence
microscopy, gelshift, and supershift experiments showed the nuclear
localization and constitutive DNA-binding activity of Stat5 in K562 cells.
Stat1 and Stat3 were constitutively activated in freshly isolated AML cells
(10 of 14 patients) and in Epstein Barr virus- positive or interleukin-10
expressing permanent LCL and BL cells. Thus, these data indicate a
differential pattern of STAT protein activation in lymphoid or myeloid
leukemia and in lymphoma cells.
Volume 88,
Issue 3,
pp. 809-816,
08/01/1996
Copyright © 1996 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. E. Hays
Heterogeneity in the AML stem cell pool
Blood,
November 5, 2009;
114(19):
3976 - 3977.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Heuser, L. M. Sly, B. Argiropoulos, F. Kuchenbauer, C. Lai, A. Weng, M. Leung, G. Lin, C. Brookes, S. Fung, et al.
Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal
Blood,
November 5, 2009;
114(19):
3983 - 3993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Benekli, H. Baumann, and M. Wetzler
Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
J. Clin. Oncol.,
September 10, 2009;
27(26):
4422 - 4432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Alvaro-Blanco, L. Martinez-Gac, E. Calonge, M. Rodriguez-Martinez, I. Molina-Privado, J. M. Redondo, J. Alcami, E. K. Flemington, and M. R. Campanero
A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence
Carcinogenesis,
March 1, 2009;
30(3):
440 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Nakayama, M. Yamamoto, K. Hayashi, H. Satoh, K. Bundo, M. Kubo, R. Goitsuka, M. A. Farrar, and D. Kitamura
BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3
Blood,
February 12, 2009;
113(7):
1483 - 1492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tun-Kyi, J. -Z. Qin, P. A. Oberholzer, A. A. Navarini, J. C. Hassel, R. Dummer, and U. Dobbeling
Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model
Ann. Onc.,
August 1, 2008;
19(8):
1488 - 1494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. McLaren, M. Rowe, and P. Brennan
Epstein-Barr virus induces a distinct form of DNA-bound STAT1 compared with that found in interferon-stimulated B lymphocytes
J. Gen. Virol.,
July 1, 2007;
88(7):
1876 - 1886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hochreiter, C. Ptaschinski, S. L. Kunkel, and R. Rochford
Murine gammaherpesvirus-68 productively infects immature dendritic cells and blocks maturation
J. Gen. Virol.,
July 1, 2007;
88(7):
1896 - 1905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Williams, U. Sarma, K. Willets, T. Smallie, F. Brennan, and B. M. J. Foxwell
Expression of Constitutively Active STAT3 Can Replicate the Cytokine-suppressive Activity of Interleukin-10 in Human Primary Macrophages
J. Biol. Chem.,
March 9, 2007;
282(10):
6965 - 6975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. S. Nagy, H. Rui, S. M. Stepkowski, J. Karras, and R. A. Kirken
A Preferential Role for STAT5, not Constitutively Active STAT3, in Promoting Survival of a Human Lymphoid Tumor
J. Immunol.,
October 15, 2006;
177(8):
5032 - 5040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kuroda, H. Puthalakath, M. S. Cragg, P. N. Kelly, P. Bouillet, D. C. S. Huang, S. Kimura, O. G. Ottmann, B. J. Druker, A. Villunger, et al.
Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic
PNAS,
October 3, 2006;
103(40):
14907 - 14912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, X. Dai, A. L. Haas, R. Wen, and D. Wang
Proteasome-dependent down-regulation of activated Stat5A in the nucleus
Blood,
July 15, 2006;
108(2):
566 - 574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Brinkmann and T. F. Schulz
Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.
J. Gen. Virol.,
May 1, 2006;
87(Pt 5):
1047 - 1074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, R. A. Kirken, L. Furian, S. Janczewska, X. Qu, W. W. Hancock, M. Wang, N. Tejpal, R. Kerman, B. D. Kahan, et al.
Allograft Rejection Requires STAT5a/b-Regulated Antiapoptotic Activity in T Cells but Not B Cells
J. Immunol.,
January 1, 2006;
176(1):
128 - 137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Higashi, J. Tsukada, Y. Yoshida, T. Mizobe, F. Mouri, Y. Minami, H. Morimoto, and Y. Tanaka
Constitutive tyrosine and serine phosphorylation of STAT4 in T-cells transformed with HTLV-I
Genes Cells,
December 1, 2005;
10(12):
1153 - 1162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Avellino, S. Romano, R. Parasole, R. Bisogni, A. Lamberti, V. Poggi, S. Venuta, and M. F. Romano
Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells
Blood,
August 15, 2005;
106(4):
1400 - 1406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yu, M. Dews, A. Park, J. W. Tobias, and A. Thomas-Tikhonenko
Inactivation of Myc in Murine Two-Hit B lymphomas Causes Dormancy with Elevated Levels of Interleukin 10 Receptor and CD20: Implications for Adjuvant Therapies
Cancer Res.,
June 15, 2005;
65(12):
5454 - 5461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Heck, D. Lengenfelder, M. Schmidt, I. Muller-Fleckenstein, B. Fleckenstein, B. Biesinger, and A. Ensser
T-Cell Growth Transformation by Herpesvirus Saimiri Is Independent of STAT3 Activation
J. Virol.,
May 1, 2005;
79(9):
5713 - 5720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Najjar, F. Baran-Marszak, C. Le Clorennec, C. Laguillier, O. Schischmanoff, I. Youlyouz-Marfak, M. Schlee, G. W. Bornkamm, M. Raphael, J. Feuillard, et al.
Latent Membrane Protein 1 Regulates STAT1 through NF-{kappa}B-Dependent Interferon Secretion in Epstein-Barr Virus-Immortalized B Cells
J. Virol.,
April 15, 2005;
79(8):
4936 - 4943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Moucadel and S. N. Constantinescu
Differential STAT5 Signaling by Ligand-dependent and Constitutively Active Cytokine Receptors
J. Biol. Chem.,
April 8, 2005;
280(14):
13364 - 13373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rahmani, E. Reese, Y. Dai, C. Bauer, L. B. Kramer, M. Huang, R. Jove, P. Dent, and S. Grant
Cotreatment with Suberanoylanilide Hydroxamic Acid and 17-Allylamino 17-demethoxygeldanamycin Synergistically Induces Apoptosis in Bcr-Abl+ Cells Sensitive and Resistant to STI571 (Imatinib Mesylate) in Association with Down-Regulation of Bcr-Abl, Abrogation of Signal Transducer and Activator of Transcription 5 Activity, and Bax Conformational Change
Mol. Pharmacol.,
April 1, 2005;
67(4):
1166 - 1176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Baran-Marszak, J. Feuillard, I. Najjar, C. Le Clorennec, J.-M. Bechet, I. Dusanter-Fourt, G. W. Bornkamm, M. Raphael, and R. Fagard
Differential roles of STAT1{alpha} and STAT1{beta} in fludarabine-induced cell cycle arrest and apoptosis in human B cells
Blood,
October 15, 2004;
104(8):
2475 - 2483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Siavash, N.G. Nikitakis, and J.J. Sauk
SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION: INSIGHTS INTO THE MOLECULAR BASIS OF ORAL CANCER
Critical Reviews in Oral Biology & Medicine,
September 1, 2004;
15(5):
298 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gate, R. S. Majumdar, A. Lunk, and K. D. Tew
Increased Myeloproliferation in Glutathione S-Transferase {pi}-deficient Mice Is Associated with a Deregulation of JNK and Janus Kinase/STAT Pathways
J. Biol. Chem.,
March 5, 2004;
279(10):
8608 - 8616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Sternberg and D. G. Gilliland
The Role of Signal Transducer and Activator of Transcription Factors in Leukemogenesis
J. Clin. Oncol.,
January 15, 2004;
22(2):
361 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Behbod, Z. S. Nagy, S. M. Stepkowski, J. Karras, C. R. Johnson, W. D. Jarvis, and R. A. Kirken
Specific Inhibition of Stat5a/b Promotes Apoptosis of IL-2-Responsive Primary and Tumor-Derived Lymphoid Cells
J. Immunol.,
October 15, 2003;
171(8):
3919 - 3927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Bharti, N. Donato, and B. B. Aggarwal
Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells
J. Immunol.,
October 1, 2003;
171(7):
3863 - 3871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Nepomuceno, C. E. Balatoni, Y. Natkunam, A. L. Snow, S. M. Krams, and O. M. Martinez
Rapamycin Inhibits the Interleukin 10 Signal Transduction Pathway and the Growth of Epstein Barr Virus B-cell Lymphomas
Cancer Res.,
August 1, 2003;
63(15):
4472 - 4480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Sriuranpong, J. I. Park, P. Amornphimoltham, V. Patel, B. D. Nelkin, and J. S. Gutkind
Epidermal Growth Factor Receptor-independent Constitutive Activation of STAT3 in Head and Neck Squamous Cell Carcinoma Is Mediated by the Autocrine/Paracrine Stimulation of the Interleukin 6/gp130 Cytokine System
Cancer Res.,
June 1, 2003;
63(11):
2948 - 2956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Spiekermann, K. Bagrintseva, R. Schwab, K. Schmieja, and W. Hiddemann
Overexpression and Constitutive Activation of FLT3 Induces STAT5 Activation in Primary Acute Myeloid Leukemia Blast Cells
Clin. Cancer Res.,
June 1, 2003;
9(6):
2140 - 2150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Benekli, M. R. Baer, H. Baumann, and M. Wetzler
Signal transducer and activator of transcription proteins in leukemias
Blood,
April 15, 2003;
101(8):
2940 - 2954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Richardson, C. Fielding, M. Rowe, and P. Brennan
Epstein-Barr Virus Regulates STAT1 through Latent Membrane Protein 1
J. Virol.,
April 1, 2003;
77(7):
4439 - 4443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. L. Leong, G. A. Andrews, D. E. Johnson, K. F. Dyer, S. Xi, J. C. Mai, P. D. Robbins, S. Gadiparthi, N. A. Burke, S. F. Watkins, et al.
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
PNAS,
April 1, 2003;
100(7):
4138 - 4143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Alas and B. Bonavida
Inhibition of Constitutive STAT3 Activity Sensitizes Resistant Non-Hodgkin's Lymphoma and Multiple Myeloma to Chemotherapeutic Drug-mediated Apoptosis
Clin. Cancer Res.,
January 1, 2003;
9(1):
316 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ikeda, K. Sato, N. Kuwada, T. Matsumura, T. Yamashita, F. Kimura, K. Hatake, K. Ikeda, and K. Motoyoshi
Interleukin-10 differently regulates monocyte chemoattractant protein-1 gene expression depending on the environment in a human monoblastic cell line, UG3
J. Leukoc. Biol.,
December 1, 2002;
72(6):
1198 - 1205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ben-Bassat, Z. Hartzstark, R. Levitzki, B. Y. Klein, Z. Shlomai, A. Gazit, and A. Levitzki
Tyrosine Kinase Inhibitors Suppress the Growth of Non-Hodgkin B Lymphomas
J. Pharmacol. Exp. Ther.,
October 1, 2002;
303(1):
163 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Testa, R. Riccioni, S. Militi, E. Coccia, E. Stellacci, P. Samoggia, R. Latagliata, G. Mariani, A. Rossini, A. Battistini, et al.
Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis
Blood,
September 26, 2002;
100(8):
2980 - 2988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Burdelya, R. Catlett-Falcone, A. Levitzki, F. Cheng, L. B. Mora, E. Sotomayor, D. Coppola, J. Sun, S. Sebti, W. S. Dalton, et al.
Combination Therapy with AG-490 and Interleukin 12 Achieves Greater Antitumor Effects than Either Agent Alone
Mol. Cancer Ther.,
September 1, 2002;
1(11):
893 - 899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Gwack, S. Hwang, C. Lim, Y. S. Won, C. H. Lee, and J. Choe
Kaposi's Sarcoma-associated Herpesvirus Open Reading Frame 50 Stimulates the Transcriptional Activity of STAT3
J. Biol. Chem.,
February 15, 2002;
277(8):
6438 - 6442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Benekli, Z. Xia, K. A. Donohue, L. A. Ford, L. A. Pixley, M. R. Baer, H. Baumann, and M. Wetzler
Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
Blood,
January 1, 2002;
99(1):
252 - 257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Lemmink, L. Tuyt, G. Knol, E. Krikke, and E. Vellenga
Identification of LIL-STAT in monocytic leukemia cells and monocytes after stimulation with interleukin-6 or interferon gamma
Blood,
December 15, 2001;
98(13):
3849 - 3852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Guasch, V. Ollendorff, J.-P. Borg, D. Birnbaum, and M.-J. Pebusque
8p12 Stem Cell Myeloproliferative Disorder: the FOP-Fibroblast Growth Factor Receptor 1 Fusion Protein of the t(6;8) Translocation Induces Cell Survival Mediated by Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt/mTOR Pathways
Mol. Cell. Biol.,
December 1, 2001;
21(23):
8129 - 8142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Z. Qin, C.-L. Zhang, J. Kamarashev, R. Dummer, G. Burg, and U. Dobbeling
Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells
Blood,
November 1, 2001;
98(9):
2778 - 2783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Fielding, K. Sandvej, A. Mehl, P. Brennan, M. Jones, and M. Rowe
Epstein-Barr Virus LMP-1 Natural Sequence Variants Differ in Their Potential To Activate Cellular Signaling Pathways
J. Virol.,
October 1, 2001;
75(19):
9129 - 9141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Ferrari, E. D. Rivadeneira, R. Jarrett, L. Stevceva, S. Takemoto, P. Markham, and G. Franchini
HVMNE, a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits
Blood,
October 1, 2001;
98(7):
2193 - 2199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kube, U. Holtick, M. Vockerodt, T. Ahmadi, B. Haier, I. Behrmann, P. C. Heinrich, V. Diehl, and H. Tesch
STAT3 is constitutively activated in Hodgkin cell lines
Blood,
August 1, 2001;
98(3):
762 - 770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Alas and B. Bonavida
Rituximab Inactivates Signal Transducer and Activation of Transcription 3 (STAT3) Activity in B-Non-Hodgkin's Lymphoma through Inhibition of the Interleukin 10 Autocrine/Paracrine Loop and Results in Down-Regulation of Bcl-2 and Sensitization to Cytotoxic Drugs
Cancer Res.,
July 1, 2001;
61(13):
5137 - 5144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-Q. Ning, J. Li, and R. J. Arceci
Signal transducer and activator of transcription 3 activation is required for Asp816 mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells
Blood,
June 1, 2001;
97(11):
3559 - 3567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Niu, K. H. Shain, M. Huang, R. Ravi, A. Bedi, W. S. Dalton, R. Jove, and H. Yu
Overexpression of a Dominant-Negative Signal Transducer and Activator of Transcription 3 Variant in Tumor Cells Leads to Production of SolubleFactors That Induce Apoptosis and Cell Cycle Arrest
Cancer Res.,
April 1, 2001;
61(8):
3276 - 3280.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Chen, J. M. Lee, Y. Zong, M. Borowitz, M. H. Ng, R. F. Ambinder, and S. D. Hayward
Linkage between STAT Regulation and Epstein-Barr Virus Gene Expression in Tumors
J. Virol.,
March 15, 2001;
75(6):
2929 - 2937.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. L. Campbell, Z. Jiang, D. M. F. Savarese, and T. M. Savarese
Increased Expression of the Interleukin-11 Receptor and Evidence of STAT3 Activation in Prostate Carcinoma
Am. J. Pathol.,
January 1, 2001;
158(1):
25 - 32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rawat, G. J. Rainey, C. D. Thompson, M. R. Frazier-Jessen, R. T. Brown, and R. P. Nordan
Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomas
Blood,
November 15, 2000;
96(10):
3514 - 3521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Kirken, R. A. Erwin, L. Wang, Y. Wang, H. Rui, and W. L. Farrar
Functional Uncoupling of the Janus Kinase 3-Stat5 Pathway in Malignant Growth of Human T Cell Leukemia Virus Type 1-Transformed Human T Cells
J. Immunol.,
November 1, 2000;
165(9):
5097 - 5104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-B. Demoulin, C. Uyttenhove, D. Lejeune, A. Mui, B. Groner, and J.-C. Renauld
STAT5 Activation Is Required for Interleukin-9-dependent Growth and Transformation of Lymphoid Cells
Cancer Res.,
July 1, 2000;
60(14):
3971 - 3977.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y.-T. Tsai, Y.-H. Su, S.-S. Fang, T.-N. Huang, Y. Qiu, Y.-S. Jou, H.-m. Shih, H.-J. Kung, and R.-H. Chen
Etk, a Btk Family Tyrosine Kinase, Mediates Cellular Transformation by Linking Src to STAT3 Activation
Mol. Cell. Biol.,
March 15, 2000;
20(6):
2043 - 2054.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Grigorieva, V. G. Grigoriev, M. K. Rowney, and R. G. Hoover
Regulation of c-myc Transcription by Interleukin-2 (IL-2). IDENTIFICATION OF A NOVEL IL-2 RESPONSE ELEMENT INTERACTING WITH STAT-4
J. Biol. Chem.,
March 15, 2000;
275(10):
7343 - 7350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Ward, I. Touw, and A. Yoshimura
The Jak-Stat pathway in normal and perturbed hematopoiesis
Blood,
January 1, 2000;
95(1):
19 - 29.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Foss and H. Prydz
Interferon Regulatory Factor 1 Mediates the Interferon-gamma Induction of the Human Immunoproteasome Subunit Multicatalytic Endopeptidase Complex-like 1
J. Biol. Chem.,
December 3, 1999;
274(49):
35196 - 35202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Turkson, T. Bowman, J. Adnane, Y. Zhang, J. Y. Djeu, M. Sekharam, D. A. Frank, L. B. Holzman, J. Wu, S. Sebti, et al.
Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein
Mol. Cell. Biol.,
November 1, 1999;
19(11):
7519 - 7528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Niu, R. Heller, R. Catlett-Falcone, D. Coppola, M. Jaroszeski, W. Dalton, R. Jove, and H. Yu
Gene Therapy with Dominant-negative Stat3 Suppresses Growth of the Murine Melanoma B16 Tumor in Vivo
Cancer Res.,
October 1, 1999;
59(20):
5059 - 5063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Uckun, O. Ek, X.-P. Liu, and C.-L. Chen
In Vivo Toxicity and Pharmacokinetic Features of the Janus Kinase 3 Inhibitor WHI-P131 [4-(4'Hydroxyphenyl)-Amino-6,7-Dimethoxyquinazoline]
Clin. Cancer Res.,
October 1, 1999;
5(10):
2954 - 2962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.D. Rivadeneira, M.G. Ferrari, R.F. Jarrett, A.A. Armstrong, P. Markham, T. Birkebak, S. Takemoto, C. Johnson-Delaney, J. Pecon-Slattery, E.A. Clark, et al.
A Novel Epstein-Barr Virus-Like Virus, HVMNE, in a Macaca Nemestrina With Mycosis Fungoides
Blood,
September 15, 1999;
94(6):
2090 - 2101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Kazansky, E. B. Kabotyanski, S. L. Wyszomierski, M. A. Mancini, and J. M. Rosen
Differential Effects of Prolactin and src/abl Kinases on the Nuclear Translocation of STAT5B and STAT5A
J. Biol. Chem.,
August 6, 1999;
274(32):
22484 - 22492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chen, J. M. Lee, Y. Wang, D. P. Huang, R. F. Ambinder, and S. D. Hayward
The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity
PNAS,
August 3, 1999;
96(16):
9339 - 9344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. de Groot, J. A.M. Raaijmakers, J.-W. J. Lammers, R. Jove, and L. Koenderman
STAT5 Activation by BCR-Abl Contributes to Transformation of K562 Leukemia Cells
Blood,
August 1, 1999;
94(3):
1108 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Ilaria Jr, R. G. Hawley, and R. A. Van Etten
Dominant Negative Mutants Implicate STAT5 in Myeloid Cell Proliferation and Neutrophil Differentiation
Blood,
June 15, 1999;
93(12):
4154 - 4166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M.-Y. Ho, B. K. Beattie, J. A. Squire, D. A. Frank, and D. L. Barber
Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling
Blood,
June 15, 1999;
93(12):
4354 - 4364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bao, S. M. Jacobs-Helber, A. E. Lawson, K. Penta, A. Wickrema, and S. T. Sawyer
Protein Kinase B (c-Akt), Phosphatidylinositol 3-Kinase, and STAT5 Are Activated by Erythropoietin (EPO) in HCD57 Erythroid Cells But Are Constitutively Active in an EPO-Independent, Apoptosis-Resistant Subclone (HCD57-SREI Cells)
Blood,
June 1, 1999;
93(11):
3757 - 3773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Lund, P. C. Prator, M. M. Medveczky, and P. G. Medveczky
The Lck Binding Domain of Herpesvirus Saimiri Tip-484 Constitutively Activates Lck and STAT3 in T Cells
J. Virol.,
February 1, 1999;
73(2):
1689 - 1694.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J.F. BROMBERG and J.E. DARNELL Jr.
Potential Roles of Stat1 and Stat3 in Cellular Transformation
Cold Spring Harb Symp Quant Biol,
January 1, 1999;
64(0):
425 - 428.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Zong, L. Zeng, Y. Jiang, H. B. Sadowski, and L.-H. Wang
Stat3 Plays an Important Role in Oncogenic Ros- and Insulin-like Growth Factor I Receptor-induced Anchorage-independent Growth
J. Biol. Chem.,
October 23, 1998;
273(43):
28065 - 28072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M.L. Tuyt, K. Bregman, C. Lummen, W. H.A. Dokter, and E. Vellenga
Differential Binding Activity of the Transcription Factor LIL-Stat in Immature and Differentiated Normal and Leukemic Myeloid Cells
Blood,
August 15, 1998;
92(4):
1364 - 1373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kirito, M. Uchida, M. Takatoku, K. Nakajima, T. Hirano, Y. Miura, and N. Komatsu
A Novel Function of Stat1alpha and Stat3 Proteins in Erythropoietin-Induced Erythroid Differentiation of a Human Leukemia Cell Line
Blood,
July 15, 1998;
92(2):
462 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Onishi, T. Nosaka, K. Misawa, A. L.-F. Mui, D. Gorman, M. McMahon, A. Miyajima, and T. Kitamura
Identification and Characterization of a Constitutively Active STAT5 Mutant That Promotes Cell Proliferation
Mol. Cell. Biol.,
July 1, 1998;
18(7):
3871 - 3879.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. C. Mulloy, T.-S. Migone, T. M. Ross, N. Ton, P. L. Green, W. J. Leonard, and G. Franchini
Human and Simian T-Cell Leukemia Viruses Type 2 (HTLV-2 and STLV-2pan-p) Transform T Cells Independently of Jak/STAT Activation
J. Virol.,
May 1, 1998;
72(5):
4408 - 4412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Turkson, T. Bowman, R. Garcia, E. Caldenhoven, R. P. De Groot, and R. Jove
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Mol. Cell. Biol.,
May 1, 1998;
18(5):
2545 - 2552.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. F. Bromberg, C. M. Horvath, D. Besser, W. W. Lathem, and J. E. Darnell Jr.
Stat3 Activation Is Required for Cellular Transformation by v-src
Mol. Cell. Biol.,
May 1, 1998;
18(5):
2553 - 2558.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Takemoto, J. C. Mulloy, A. Cereseto, T.-S. Migone, B. K. R. Patel, M. Matsuoka, K. Yamaguchi, K. Takatsuki, S. Kamihira, J. D. White, et al.
Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins
PNAS,
December 9, 1997;
94(25):
13897 - 13902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Saharinen, N. Ekman, K. Sarvas, P. Parker, K. Alitalo, and O. Silvennoinen
The Bmx Tyrosine Kinase Induces Activation of the Stat Signaling Pathway, Which Is Specifically Inhibited by Protein Kinase Cdelta
Blood,
December 1, 1997;
90(11):
4341 - 4353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Priel-Halachmi, I. Ben-Dor, S. Shpungin, T. Tennenbaum, H. Molavani, M. Bachrach, S. Salzberg, and U. Nir
FER Kinase Activation of Stat3 Is Determined by the N-terminal Sequence
J. Biol. Chem.,
September 8, 2000;
275(37):
28902 - 28910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Brennan, J. E. Floettmann, A. Mehl, M. Jones, and M. Rowe
Mechanism of Action of a Novel Latent Membrane Protein-1 Dominant Negative
J. Biol. Chem.,
January 5, 2001;
276(2):
1195 - 1203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Y. Jui, R.-J. Tseng, X. Wen, H.-I Fang, L.-M. Huang, K.-Y. Chen, H.-J. Kung, D. K. Ann, and H.-M. Shih
Protein-tyrosine Phosphatase D1, a Potential Regulator and Effector for Tec Family Kinases
J. Biol. Chem.,
December 22, 2000;
275(52):
41124 - 41132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ariyoshi, T. Nosaka, K. Yamada, M. Onishi, Y. Oka, A. Miyajima, and T. Kitamura
Constitutive Activation of STAT5 by a Point Mutation in the SH2 Domain
J. Biol. Chem.,
August 4, 2000;
275(32):
24407 - 24413.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|